Literature DB >> 16987984

Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon.

Bianca Dauber1, Jana Schneider, Thorsten Wolff.   

Abstract

Expression of alpha/beta interferon (IFN-alpha/beta) in virus-infected vertebrate cells is a key event in the establishment of a sustained antiviral response, which is triggered by double-stranded RNA (dsRNA) produced during viral replication. These antiviral cytokines initiate the expression of cellular proteins with activities that limit the replication and spread of the invading viruses. Within this response, the dsRNA-dependent protein kinase R (PKR) that is expressed at constitutive levels and upregulated by IFN-alpha/beta acts as an important antiviral effector that can block the cellular translational machinery. We previously demonstrated that efficient replication of influenza B virus depends on the viral dsRNA-binding NS1 protein that inhibits the transcriptional activation of IFN-alpha/beta genes. Here we tested the postulate that the viral NS1 protein counteracts antiviral responses through sequestering intracellular dsRNA by analyzing a collection of recombinant influenza B viruses. As expected, viruses expressing dsRNA-binding-defective NS1 proteins were strongly attenuated for replication in IFN-competent hosts. Interestingly, these virus mutants failed to prevent activation of PKR but could effectively limit IFN induction. Conversely, a mutant virus expressing the N-terminal dsRNA-binding domain of NS1 prevented PKR activation, but not IFN induction, suggesting an important role for the NS1 C-terminal part in silencing the activation route of IFN-alpha/beta genes. Thus, our findings indicate an unexpected mechanistic dichotomy of the influenza B virus NS1 protein in the suppression of antiviral responses, which involves at least one activity that is largely separable from dsRNA binding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987984      PMCID: PMC1642593          DOI: 10.1128/JVI.01142-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors.

Authors:  Stephan Ludwig; Xiuyan Wang; Christina Ehrhardt; Hongyong Zheng; Nicola Donelan; Oliver Planz; Stephan Pleschka; Adolfo García-Sastre; Gudrun Heins; Thorsten Wolff
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

Review 4.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

Review 5.  Inhibition of PKR by RNA and DNA viruses.

Authors:  Jeffrey O Langland; Jason M Cameron; Michael C Heck; James K Jancovich; Bertram L Jacobs
Journal:  Virus Res       Date:  2006-05-15       Impact factor: 3.303

6.  Nonsense mutations affecting the lengths of the NS1 nonstructural proteins of influenza A virus isolates.

Authors:  J D Parvin; J F Young; P Palese
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

7.  Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3.

Authors:  Martin Spiegel; Andreas Pichlmair; Luis Martínez-Sobrido; Jerome Cros; Adolfo García-Sastre; Otto Haller; Friedemann Weber
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 8.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

9.  Type I interferons produced by dendritic cells promote their phenotypic and functional activation.

Authors:  Maria Montoya; Giovanna Schiavoni; Fabrizio Mattei; Ion Gresser; Filippo Belardelli; Persephone Borrow; David F Tough
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

10.  IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA.

Authors:  Kristi L Peters; Heather L Smith; George R Stark; Ganes C Sen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

View more
  31 in total

Review 1.  Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.

Authors:  Cyril X George; Zhiqun Li; Kristina M Okonski; Ann M Toth; Ying Wang; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

Review 2.  Innate immune evasion strategies of influenza viruses.

Authors:  Benjamin G Hale; Randy A Albrecht; Adolfo García-Sastre
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

3.  Limited compatibility of polymerase subunit interactions in influenza A and B viruses.

Authors:  Kerstin Wunderlich; Mindaugas Juozapaitis; Benjamin Mänz; Daniel Mayer; Veronika Götz; Andrea Zöhner; Thorsten Wolff; Martin Schwemmle; Arnold Martin
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

4.  Activation of phosphatidylinositol 3-kinase signaling by the nonstructural NS1 protein is not conserved among type A and B influenza viruses.

Authors:  Christina Ehrhardt; Thorsten Wolff; Stephan Ludwig
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

5.  Analysis of influenza B Virus NS1 protein trafficking reveals a novel interaction with nuclear speckle domains.

Authors:  Jana Schneider; Bianca Dauber; Krister Melén; Ilkka Julkunen; Thorsten Wolff
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

6.  Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach.

Authors:  Rong Hai; Luis Martínez-Sobrido; Kathryn A Fraser; Juan Ayllon; Adolfo García-Sastre; Peter Palese
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

7.  Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association.

Authors:  Jean-François Clément; Annie Bibeau-Poirier; Simon-Pierre Gravel; Nathalie Grandvaux; Eric Bonneil; Pierre Thibault; Sylvain Meloche; Marc J Servant
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

Review 8.  Negative regulation of cytoplasmic RNA-mediated antiviral signaling.

Authors:  Akihiko Komuro; Darja Bamming; Curt M Horvath
Journal:  Cytokine       Date:  2008-08-13       Impact factor: 3.861

9.  Robust Lys63-Linked Ubiquitination of RIG-I Promotes Cytokine Eruption in Early Influenza B Virus Infection.

Authors:  Jingwen Jiang; Jing Li; Wenhui Fan; Weinan Zheng; Meng Yu; Can Chen; Lei Sun; Yuhai Bi; Chan Ding; George F Gao; Wenjun Liu
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

10.  A Second RNA-Binding Site in the NS1 Protein of Influenza B Virus.

Authors:  Li-Chung Ma; Rongjin Guan; Keith Hamilton; James M Aramini; Lei Mao; Shanshan Wang; Robert M Krug; Gaetano T Montelione
Journal:  Structure       Date:  2016-08-18       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.